Cipla Q3 FY11 Results : Net profit declines 19.49%

by khalid on 05/02/2011 · 0 comments

Mumbai based pharma company Cipla Limited has posted a net profit for the period Q3 (ending Dec 10) of the current fiscal (FY10-11). During the said quarter, net profit declines 19.49% to Rs 232.69 crores in comparison to Rs 289.03 crores of Q3 (ending Dec 09) of previous year (FY09-10). Cipla Limited is a prominent Indian pharmaceutical company, best-known outside its home country for manufacturing low-cost anti-AIDS drugs for HIV-positive patients in developing countries. The company was founded by Khwaja Abdul Hamied as The Chemical, Industrial & Pharmaceutical Laboratories (CIPLA) in 1935.

The company has informed the share market (BSE/NSE) that the total income rose 8.44% to Rs 1579.36 crore in Q3 (ending Dec 2010) of the current fiscal (FY10-11) when compared with the same quarter Q3 (ending Dec 2009) of previous year (FY09-10). Total income was Rs 1456.64 crores in last year’s quarter Q3.

Share’s Data :-
BSE Code : 500087
Mkt. Cap : Rs 26,030.02 Crores
Cipla Ltd. share’s CMP is Rs 324.20 on 4th Feb 2011.

Stay tuned to BelltheBull Blog for more news on Cipla Limited !

Related Posts Plugin for WordPress, Blogger...

Leave a Comment

Previous post:

Next post: